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ABSTRACT
Background: It is vital that the treatment offered at transgender health services can be evaluated to
ensure a high quality of care. However, the tools currently used to evaluate treatment at
transgender health services are limited by mainly focusing on mental health or because they have
been developed for binary transgender people only. This study therefore aimed to develop and
validate a tool that addresses these limitations. The Gender Congruence and Life Satisfaction Scale
(GCLS) was developed through reviewing the literature, conducting interviews with transgender
people, and holding discussions with experts working in transgender healthcare. An initial pool of
items was developed and feedback on these was obtained. The tool was then validated.
Method: For the validation of the tool, a total of 789 participants (451 transgender [171
transgender females, 147 transgender males, 133 people identifying as non-binary], and 338
cisgender [254 females, 84 males]) were recruited from the United Kingdom to test the factor
structure and validity of the GCLS.
Results: Exploratory factor analysis retained 38 items which formed seven subscales (psychological
functioning; genitalia; social gender role recognition; physical and emotional intimacy; chest; other
secondary sex characteristics; and life satisfaction). These seven subscales were found to have good
internal consistency and convergent validity. The GCLS was also found to be capable of
discriminating between groups (e.g., people who have and have not undergone gender afﬁrming
medical interventions). Transgender and cisgender subscale norms are provided for the GCLS.
Conclusion: The GCLS is a suitable tool to use with the transgender population to measure health-
related outcomes for both clinical and research purposes.
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Transgender people are those who experience a discrep-
ancy between the gender they were assigned at birth and
their gender identity. Transgender males are people who
were assigned female at birth, on the basis of their sexual
characteristics, but identify asmale. Transgender females
are people who were assigned male at birth, on the basis
of their sexual characteristics, but identity as female.
Some transgender people may also identify between or
outside the binary gender spectrum. These people may
choose to identify as gender neutral (feeling that one is
neither male nor female), non-gender (having no gender
in relation to presentation), or gender queer (identifying
and presenting in a way that is outside the gender dichot-
omy of male and female) (Arcelus & Bouman, 2017;
Richards, Bouman, & Barker, 2017; Richards et al.,
2016). Some people may also be more ﬂuid with their
gender identity whereby they do not have a ﬁxed gender
and it can therefore vary over time. Cisgender people do
not experience such discrepancy (Arcelus & Bouman,
2017; Bouman et al., 2017). Many transgender people
experience high levels of distress due to the discrepancy
between their birth-assigned gender and gender identity
(e.g., Beek, Kreukels, Cohen-Kettenis, & Steensma,
2015). To alleviate this distress, many transgender people
will approach transgender health services in order to
access gender afﬁrming medical interventions (GAMI)
to help them transition to the gender they identify with.
Health professionals working at transgender health serv-
ices may start their patients on cross-sex hormone
treatment to induce either masculinization (with testos-
terone) or feminization (with estrogen and often with
testosterone-blocking medication), depending on the
CONTACT Prof. Jon Arcelus Jon.Arcelus@nottingham.ac.uk Institute of Mental Health, Jubilee Campus, Triumph Road, University of Nottingham,
Nottingham NG7 2TU, United Kingdom.
© 2018 Bethany A. Jones, Walter Pierre Bouman, Emma Haycraft, and Jon Arcelus. Published with license by Taylor & Francis Group, LLC
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/
4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in
any way.
INTERNATIONAL JOURNAL OF TRANSGENDERISM
https://doi.org/10.1080/15532739.2018.1453425
patient’s gender identity (Coleman et al., 2012; Wylie
et al., 2014). After living as their experienced gender,
transgender people, if they wish to do so, can be referred
for gender afﬁrming surgery (Coleman et al., 2012;Wylie
et al., 2014).
Transgender health services throughout Europe and
North America have seen a substantial increase in the
number of referrals in recent years. This has put a
strain on these services, especially in relation to waiting
times for assessment and treatment (Aitken et al.,
2015; de Vries, Kreukels, T’Sjoen, A

lgars, & Mattila,
2015). In the United Kingdom (UK), patients can
expect to wait more than 1 year before their ﬁrst
appointment at a transgender health service (Bouman
& Richards, 2013; UK Trans Info, 2016). In light of
this, evaluating the care and treatment received at these
services is important. This will allow for the quality of
care to be improved and will also facilitate the identiﬁ-
cation of service and personal factors associated with
positive and negative outcomes (e.g., Dawson, Doll,
Fitzpatrick, Jenkinson, & Carr, 2010). If factors associ-
ated with positive and negative outcomes of transgen-
der health services can be identiﬁed, patient-centered
services can be created which provide extra support for
patients who are vulnerable to poorer outcomes. Iden-
tiﬁcation of these factors may also help to make the
treatment process timely and more efﬁcient for patients
who are deemed not to be vulnerable. Patient-centered
services are crucial in improving patient outcomes
(e.g., Lauver et al., 2002). In addition, within national-
ized social healthcare systems which are present in
most European countries, access to care, including
transgender healthcare is free at the point of access for
all citizens. However, these healthcare systems have
limited resources and, at some point, rationing deci-
sions may have to be made. Tools that predict which
interventions are associated with good outcomes are
vital to assist with making decisions regarding the allo-
cation of healthcare resources and to explore how to
improve overall patient outcomes.
Research has explored patient treatment outcomes
post-gender afﬁrming interventions, such as cross-sex
hormones and gender afﬁrming genital surgery. On
the whole, these studies have demonstrated that men-
tal health and quality of life improve following gender
afﬁrming medical interventions (e.g., Dhejne, Van
Vlerken, Heylens, & Arcelus, 2016; Jones, Haycraft,
Murjan, & Arcelus, 2016; Marshall, Claes, Bouman,
Witcomb, & Arcelus, 2016; Murad et al., 2010; Van de
Grift et al., 2018; Witcomb et al., 2018). The main
focus of outcome evaluations at transgender health
services has often been based around mental health
symptoms (e.g., anxiety, depression) (e.g., Bouman
et al., 2016, 2017; Heylens et al., 2014; Murad et al.,
2010; Witcomb et al., 2018). While mental health is
evidently an important aspect to include within any
outcome assessment of gender afﬁrming medical
interventions, given the high prevalence of mental
health problems transgender people often experience
pre-gender afﬁrming medical interventions (Dhejne
et al., 2016), it should not be the sole focus. Research-
ers have argued that improvements in mental health
should not be the only focus of transgender health ser-
vice evaluations, as mental health interventions are
generally not provided by transgender health services
(Arcelus & Bouman, 2015; Dhejne et al., 2016). Patient
outcomes will also be biased by levels of mental health
problems experienced pre-treatment. Moreover, the
treatment pathways for transgender people consist of
multidisciplinary treatment options, which further
complicates the evaluation of these interventions.
One of the most important outcomes that should be
measured after gender afﬁrming medical interventions
is a change in the distress and unhappiness a person
experiences with their experienced gender and body
as a result of their gender identity being at odds with
their assigned gender (i.e., gender incongruence).
Measurement of this outcome is often neglected due
to the lack of available measures that have been devel-
oped with the transgender population and are capable
of assessing a change in distress and unhappiness a
person experiences with their gender and body. The
few measures that are available to assess gender dis-
tress (such as the Utrecht Gender Dysphoria Scale;
Cohen-Kettenis & van Goozen, 1997) and body dissat-
isfaction (such as the Hamburg Body Drawing Scale;
Becker et al., 2016), although useful, are limited. These
measures have been developed with the binary gender
system in mind (i.e., male or female) which is prob-
lematic in light of an increasing number of people
identifying as non-binary or outside the gender binary
(Beek et al., 2015; Clarke, Veale, Townsend, Frohard-
Dourlent, & Saewyc, 2018; Richards et al., 2016, 2017);
also, participants are asked to complete different ver-
sions depending on the gender they were assigned at
birth. Measures developed to assess treatment out-
comes within the transgender population therefore
need to ensure they encapsulate people with non-
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binary gender identities and be gender neutral (i.e.,
applicable to all genders). A gender neutral measure
also allows clinicians to assess outcomes using the
same tool throughout the medical transition.
In addition, for outcome evaluations to be mean-
ingful, the measures employed must have been devel-
oped for, and validated with, the population in
question (Dawson et al., 2010). Currently, mental
health and quality of life measures that are used to
assess patient outcomes at transgender health services
have often been developed for use with other speciﬁc
(and dissimilar) populations (e.g., Eating Disorder
Inventory-2; Garner, 1991) or the general population
(e.g., Hospital Anxiety and Depression Scale; Zigmond
& Snaith, 1983). Therefore, these measures are
unlikely to be speciﬁc enough (i.e., unlikely to ask
about mental health problems in relation to gender
distress) to be used with the transgender population
for meaningful evaluations. Due to the lack of a suit-
able, validated mental health and quality of life mea-
sure, transgender health services usually invite
patients to complete a series of measures that assess
different constructs relating to mental health and
quality of life to ensure evaluations are comprehen-
sive. Research has found respondent burden to be
great when patients are asked to complete multiple
questionnaires, especially when these questionnaires
assess similar constructs (Rolstad, Adler, & Ryden,
2011; Turner et al., 2007). Respondent burden can
affect the quality of data gathered and may reduce
response rates (Diehr, Chen, Patrick, Feng, & Yasui,
2005; Snyder et al., 2007). In light of this, treatment
evaluations collected at transgender health services
may be of a poor quality as they might have been
affected by respondent burden.
Aims
The objective of this study was to develop a self-report
tool that was capable of assessing the outcomes of
transgender health services. Patients are referred to
transgender health services as a consequence of
experiencing gender incongruence and therefore in the
short-term the main aim of the tool was to assess levels
of gender distress, gender congruence, and associated
mental well-being. It was also expected that the tool
would be able to assess long-term outcomes bymeasur-
ing levels of life satisfaction and psychological well-
being. Such a tool is imperative to ensure evaluations
are mapped onto the most important aims of gender
afﬁrming medical treatment and to allow meaningful
and efﬁcient evaluations to take place at transgender
health services. The tool that was developed in the cur-
rent study has been named the Gender Congruence
and Life Satisfaction Scale (GCLS). Details of the devel-
opment of the GCLS will be provided in the methods
section. Once the tool had been developed, the ﬁrst aim
of this study was to explore the factor structure of the
GCLS. The second aim was to explore the convergent
and discriminant validity of the GCLS (types of con-
struct validity). The ﬁnal aim was to determine whether
the GCLS can distinguish between subgroups (i.e.,
transgender and cisgender people) and be sensitive to
changes in gender distress, gender incongruence, asso-
ciated mental well-being, and life satisfaction through-
out the treatment process (known-groups validity; a
further type of construct validity). The ﬁnal aim there-
fore also provides an opportunity to pilot the GCLS
with transgender people and provides subscale norms.
Method
Participants and recruitment
Two different groups of participants were involved
in this study: transgender people and cisgender
(non-trans) people. Part of the study sample com-
prised transgender people who were invited to take
part from a national transgender health service
within the UK. This is a National Health Service
(NHS) funded center, which offers assessment and
treatment to transgender people who are pursuing,
or are considering, medical transition. The center is
one of the larger transgender healthcare services in
Europe and receives around 1,000 referrals a year
from England and Wales. This service accepts
referrals from people aged 17 and over. Clinicians
at the service informed participants of the existence
of the study and provided them with the informa-
tion sheet and details about how to participate.
Some transgender people and all of the cisgender
participants were recruited through the community via
snowball sampling. All transgender and cisgender peo-
ple recruited through the community were required to
be aged 18 or over. This was achieved by sharing an
online link to the study with transgender support
organizations (for transgender people only), via social
media websites, and by email. The content of this
advertisement was the same for transgender and
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cisgender people recruited through the community.
Participants who took part in the online survey were
then asked to pass the link onto others in their network.
Recruitment took place over 4 months in 2016. A
total of 458 transgender participants were invited.
However, from this sample, seven people were
removed as they either had provided no information
about their gender assigned at birth and gender iden-
tity (n D 3) or had not indicated whether or not their
gender assigned at birth and gender identity were the
same (n D 4). Thus, the ﬁnal sample consisted of 451
transgender people. In addition, a total of 375 cisgen-
der participants were invited. Of these participants, 37
were removed as they reported a gender identity that
was different from the gender they were assigned at
birth. The ﬁnal cisgender sample consisted of 338 par-
ticipants. The ﬁnal sample size therefore included 789
participants (338 identiﬁed as cisgender [42.8%] and
451 as transgender [57.2%]).
Procedure
After participants had read through the information
sheet and decided whether or not they would like to
take part, they were invited to complete the ﬁrst itera-
tion of the newly developed tool (GCLS). Participants
recruited from the transgender health service were
either asked to complete a paper questionnaire pack
in their own time and return this to the service in a
pre-paid envelope or complete the online survey.
Community participants were asked to complete the
survey online. No paper alternative was offered.
Informed consent was obtained from all participants
prior to taking part in the study.
The study was approved by an NHS research ethics
committee and by the Research and Development
Department of Nottinghamshire Healthcare NHS
Foundation Trust (16/EM/0183) in line with Health
Research Authority guidance (HRA, 2013), as well as
Loughborough University Research Ethics Committee.
Development of the Gender Congruence and Life
Satisfaction Scale (GCLS)
Several processes were undertaken to complete the
development of the GCLS. First, systematic reviews of
the available literature on treatment outcomes, includ-
ing body dissatisfaction (see Jones et al., 2016) and
mental health were conducted (see Dhejne et al.,
2016). This was followed by a review of existing body
dissatisfaction measures that are currently used to
assess patient outcomes at transgender health services
(Jones et al., 2016). Next, in-depth interviews with 14
transgender people attending a national transgender
health service in the UK were undertaken as part of a
larger study (Jones, Arcelus, Bouman, & Haycraft,
2017). These interviews highlighted how distress and
dissatisfaction with gender, associated mental well-
being, and life satisfaction improved over the
treatment process. The study provided valuable infor-
mation regarding the most important objectives of
transgender health services from the patients’ point of
view. Following this, several discussions and focus
groups took place with clinicians from different trans-
gender health services in the UK, Sweden, and Bel-
gium. All of the outlined processes and studies
mentioned above informed the ﬁrst draft of the GCLS.
The items within this ﬁrst draft were developed as a
result of the authors reviewing other self-report meas-
ures relating to gender incongruence, gender distress,
mental well-being (including body dissatisfaction),
and life satisfaction used with the transgender and cis-
gender population. This promoted a discussion among
the research team about some of the limitations of
these measures (e.g., not transgender speciﬁc, devel-
oped within the binary gender system). Some of the
limitations were identiﬁed through earlier phases of
development (i.e., the review of existing measure used
to assess body dissatisfaction). The team then worked
together to develop a list of items while taking into
consideration some of the limitations identiﬁed in the
previous phase. To be a valid item it had to: (1) be
related to gender incongruence, gender distress, men-
tal well-being, or life satisfaction; (2) assess this con-
struct in relation to gender incongruence and/or
gender distress (e.g., I have felt extremely distressed
when looking at my genitals); (3) be gender neutral.
This process resulted in 85 items being developed.
The ﬁrst draft of the GCLS was then discussed with
the Nottingham Centre for Transgender Health Ser-
vice User Research Advisory Group (SURAG). This
group consisted of 21 people, who were attending, or
had attended the service and agreed to provide feed-
back for research projects taking place at the service.
This consultation resulted in a revised draft of the
GCLS. The authors also worked in consultation with
transgender people in the community, who were
recruited through charities and support organizations
for transgender and LGBT people within the UK. This
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included asking people to comment on the tool and
the items that comprised it. Feedback was collected
which allowed the development of the next draft of
the scale, which was shared with several clinicians and
academics in the ﬁeld, including clinical academics
from outside the UK (Sweden and Belgium). Follow-
ing feedback, several drafts were developed which
were discussed with the above groups until a tool that
satisﬁed everyone was created. This process resulted
in a tool with 42 items initially being created.
Measures
Socio-demographic questions: Information about par-
ticipants’ age, their gender assigned at birth, and gen-
der identity was collected. Participants were invited to
provide information (if applicable) about their gender
transition, including the amount of time they spend
living in their experienced gender in their daily lives
(less than 50%, more than 50%, or 100% of the time).
They were also asked whether they were using cross-
sex hormones and/or blockers (if relevant) and
whether they had undergone any gender afﬁrming
surgery (“Yes” or “No” response style). On the online
survey, these questions were only visible to individuals
who indicated incongruence between their birth and
experienced gender (i.e., these questions were not visi-
ble to cisgender participants).
Gender Congruence and Life Satisfaction Scale
(GCLS; see the Appendix): This 38-item scale aims to
assess change and measure improvements in gender
(in)congruence, related mental well-being, and life sat-
isfaction throughout the process of undergoing gender
afﬁrming medical interventions. The scale is indepen-
dent of gender assigned at birth and was developed to
be relevant to people who identify as male, female, as
well as those who identify outside the binary gender
system (e.g., non-binary identities). The GCLS asks
respondents to think about how they have felt over
the last 6 months and to rate their responses on a 5-
point Likert scale (always D 1; never D 5). Although
the GCLS is not a diagnostic tool, the 6 month time-
frame was selected to align with the diagnosis of
Gender Dysphoria in the Diagnostic and Statistical
Manual of Mental Disorders (DSM), ﬁfth edition
(APA, 2013). The timeframe in the DSM-5 was
decided on by clinical consensus to reﬂect the mini-
mum duration that transgender people have to experi-
ence gender incongruence and distress in order to
establish that these feelings are persistent rather than
transient. It therefore felt important to apply the same
criterion to the GCLS. It should be noted that there is
no empirical evidence to support the 6 month time-
frame speciﬁed in the DSM-5. Mean scores were cal-
culated for each subscale. In the ﬁnal (38 item)
version of the scale, 11 items were reverse coded (i.e.,
never D 1; always D 5). A higher score indicates a
greater gender congruence, greater gender-related
well-being, and greater life satisfaction. In contrast, a
lower score indicates lower gender congruence, poorer
gender-related well-being, and poorer general life
satisfaction.
Hamburg Body Drawing Scale (HBDS; Becker et al.,
2016): This scale was originally developed by Appelt
and Strauss (1988) for use with individuals with differ-
ent forms of psychoendocrinological disorders and
assesses satisfaction with 33 different body parts. Becker
et al. (2016) recently validated the scale with the trans-
gender population and adapted it to include male and
female-speciﬁc subscales. There is also an item that
assesses overall satisfaction with appearance. This was
the only item used in the current study and the reason
for including it was to assess the convergent validity of
the GCLS (i.e., to determine whether two measures that
theoretically should be related, are related). The male
and female subscales were not used within the current
study as they were felt to be inappropriate to use with
people who identify as non-binary. Participants were
asked to rate their responses on a 5-point Likert scale
(1 D very dissatisﬁed; 5 D very satisﬁed) and therefore
a higher score indicates a higher level of body satisfac-
tion. Becker et al. (2016) found the HBDS subscales to
have good reliability in a transgender population (a D
.62–.91). As it was not possible to conduct reliability
analysis with just one item, this was not calculated in
the current study.
Transgender Congruence Scale (TCS; Kozee, Tylka,
& Bauerband, 2012): This measure has 12 questions,
of which nine correspond with “appearance congru-
ence” (e.g., I do not feel that my appearance reﬂects my
gender identity; I am generally comfortable with how
others perceive my gender identity when they look at
me) and three relating to “gender identity acceptance”
(e.g., I am not proud of my gender identity). Mean
scores were calculated for each subscale. A global score
can also be calculated by ﬁnding the mean of all
responses. In the current study, only the 9-item
appearance congruence subscale was used to assess
INTERNATIONAL JOURNAL OF TRANSGENDERISM 5
convergent validity. Responses were rated on a 5-point
scale from 1 D strongly disagree to 5 D strongly agree.
A higher score indicates a higher level of transgender
congruence. This measure has been found to have
good reliability (a D .93; Kozee et al., 2012) and in the
current sample, the appearance congruence subscale
had excellent reliability (a D .96).
World Health Organization Quality of Life-BREF
(WHOQOL-BREF; Harper, 1998): The WHOQOL-
BREF has 26 items, which measures four domains: psy-
chological, physical, relationships, and environment.
There are also two items which are assessed separately,
that ask about overall quality of life and overall health. In
the current study, the psychological and relationships
subscales were used as well as the item that assessed over-
all quality of life, so as to assess convergent validity. The
questions were rated on a 5-point Likert scale (1 D very
dissatisﬁed; 5 D very satisﬁed) and a higher score indi-
cates a higher quality of life. The subscale scores were cal-
culated using the mean and then multiplied by four. This
is to make the scores from the WHOQOL-BREF compa-
rable to the WHOQOL-100 (Harper, 1998), which is the
longer original questionnaire. The WHOQOL-BREF has
been found to have good to excellent reliability and valid-
ity in the general population and in clinical populations
(e.g., rehabilitation, primary care, mental health) across
23 countries (Skevington, Lofty, & O’Connell, 2004). In
this study, the psychological (a D .89) and relationships
(a D .76) subscales had very good reliability.
Internet Gaming Disorder Scale-Short Form (IGDS;
Pontes & Grifﬁths, 2015): This measure is a brief 9-item
questionnaire that assesses internet gaming behavior (e.g.,
Do you systematically fail when trying to control or cease
your gaming activity?). Participants were asked to rate
their responses on a 5-point Likert scale (1 D never; 5 D
very often). Scores range from 9 to 45 and were calculated
by summing all responses. A higher score indicates more
problematic gaming behavior. The measure has good reli-
ability (a D .87) (Pontes & Grifﬁths, 2015) and in this
study had excellent reliability (a D .92). This measure was
included within the current study to assess discriminant
validity (i.e., to determine whether two measures were not
related, as would theoretically be expected).
Statistical analysis
For the ﬁrst aim of the study, principal component anal-
ysis was conducted with data from the transgender par-
ticipants only to determine the factor structure of GCLS.
For factor analysis, Comrey and Lee (1992) suggested
that 300 participants is a good sample size and therefore
the number of transgender participants (nD 451) is con-
sidered adequate. For the second aim, convergent and
discriminant validity testing was conducted. To assess
convergent and discriminant validity, one-tailed Spear-
man’s Rho correlations (as the data were not normally
distributed) were conducted between the GCLS and the
WHOQOL, HBDS, TCS, and IGDS with the transgender
participants only (n D 451). As multiple comparisons
were conducted, Bonferroni corrections were used (.05
 13 D .004). For the ﬁnal aim, known-groups validity
testing (another form of construct validity) was con-
ducted. This analysis determines whether known-groups
within the dataset, in this circumstance transgender peo-
ple at different stages of their transition (i.e., cross-sex
hormones versus no cross-sex hormones) and cisgender
people score in a theoretically expected way on the GCLS
(e.g., transgender people score lower than cisgender peo-
ple indicating a poorer outcome). Norm values were also
generated for the GCLS subscales, global scale, and clus-
ters explored among the different groups. One-tailed
Mann–Whitney U tests were conducted for this aim as
the data were not normally distributed. The signiﬁcance
level was set at p< .05.
Results
Descriptive statistics relating to the gender identities of
the transgender people are displayed in Table 1. The
mean age of the transgender participants was 36.94 (SD
D 15.46) and ranged from 17 to 77 years. Of the 451
transgender people, 189 (41.9%) had not undergone
any gender afﬁrming medical intervention, 145 (32.2%)
had taken cross-sex hormone treatment only, 22 (4.9%)
had taken cross-sex hormones and undergone chest
reconstructive surgery only, 92 (20.4%) had taken
cross-sex hormone treatment and undergone genital
surgery (C / – chest reconstructive surgery) and three
(.7) had undergone genital surgery but were not taking
cross-sex hormone treatment. In the cisgender sample,
84 (24.9%) were male and 254 female (75.1%). The
mean age of the cisgender sample was 36.52 (SD D
12.23) and ranged from 19 to 70 years.
Aim 1: Factor structure of GCLS
Preliminary analyses
To explore the factor structure of the GCLS, principal
component analysis was conducted. It was expected
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that the items on the GCLS would be related and so
therefore oblique (direct oblimin criterion) rotation
was employed. As preliminary analysis, multicolli-
nearity and singularity were assessed. The determinant
was above .00001 and therefore multicollinearity and
singularity were not a cause for concern. Bartlett’s test
of sphericity was also signiﬁcant (p < .001) suggesting
that correlations between variables were signiﬁcantly
different from zero and therefore it was concluded
that variables were adequately related to ﬁnd clusters
within the dataset.
Exploratory factor analysis and item elimination
Analysis to determine the number of factors to retain
was conducted. Kaiser (1960) suggested that factors
with an eigenvalue greater than one should be
retained. Kaiser’s criterion is seen to be accurate when
the sample size exceeds 250 (current sample n D 451)
and the average communality is equal or greater than
.6 (.67 in the current study; Field, 2013). Seven factors
with an eigenvalue greater than one were identiﬁed
and explained 67.30% of the total variance. In con-
trast, the scree plot suggested ﬁve factors should be
extracted (Cattell, 1966). Courtney and Gordon
(2013) recommended that other statistical techniques
(other than the eigenvalue and scree plot) should also
be used to establish the number of factors to extract.
Additional analysis was therefore conducted and Rus-
cio and Roche’s (2012) comparative data technique
suggested seven factors should be retained, as did
Velicer’s (1976) minimum average partial (MAP) test.
Courtney and Gordon (2013) found Ruscio and
Roche’s (2012) comparative data technique to have
87.14% accuracy and Velicer’s (1976) MAP test to
have 59.6% accuracy in determining the number of
factors to retain. Based on these analyses, seven factors
were explored.
Item retention and elimination were subsequently
considered in accordance with several criteria. Stevens
(2002) suggested that for a sample size greater than
300 (current sample n D 451), item loadings should
be greater than .30 to be retained within a factor. All
item loadings in the current study were above .30 and
therefore all 42 items were retained at this stage. Next,
the interpretability of items was explored by an expert
panel working in the area of transgender health (n D
8) and any items which were not found to theoretically
or conceptually ﬁt within the factor they had been
placed were excluded. Based on this review, items 21,
27, 28, and 30 were excluded. When items cross-
loaded simultaneously onto two (or more) factors
with a difference of less than .10, the face validity of
the item was considered. This applied to items 10, 19,
26, and 41. Items 10 (¡.39), 26 (.42), and 41 (¡.39)
were felt to conceptually ﬁt better within the factors
that they loaded highest with and therefore were
retained within these factors. It was also felt that item
19 did not conceptually ﬁt within factor 1 (the factor
which the item loaded the highest, .41), however it
also loaded highly onto factor 3 (.39) and was felt to
conceptually ﬁt better within this factor (in compari-
son to factor 1). Therefore, item 19 was retained
within factor 3. In total, four items were removed
which resulted in the revised version of the GCLS
comprising 38 items.
Analysis of the remaining 38 items
The remaining 38 items were then subjected to a sec-
ond principle components analysis with oblique
(direct oblimin criterion) rotation. Seven factors had
an eigenvalue greater than one, which explained a
large proportion of the overall variance (68.01%; see
Table 2). All item loadings were greater than .30 and
all items conceptually and theoretically ﬁtted within
the factor that they had been placed. The only excep-
tion to this rule was item 19, which loaded highly onto
factor 1 and factor 3 and was moved from factor 1 to
3 as it was felt to better conceptually ﬁt within factor
3. Therefore, 38 items were retained to comprise the
ﬁnal version of the GCLS.
Table 1. Gender identities of the transgender sample by stage of medical transition.
Whole transgender
sample
(n D 451) (%)
No GAMI
group
(n D 189) (%)
CHT only (n D 145)
(%)
CHT and chest
surgery only
(n D 22) (%)
CHT and genital surgery
(C / – chest surgery) (n D
92) (%)
Genital surgery but no CHT (n
D 3) (%)
Transgender
female
171 (37.9) 45 (23.8) 78 (53.8) 0 47 (51.1) 1 (33.3)
Transgender male 147 (32.6) 46 (24.4) 50 (34.5) 17 (77.4) 33 (35.8) 1 (33.3)
Non-binary 133 (29.5) 98 (51.8) 17 (11.7) 5 (22.6) 12 (13.1) 1 (33.3)
Note. CHT: Cross-sex Hormone Treatment; GAMI: Gender Afﬁrming Medical Intervention.
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The ﬁrst factor (10 items) included items that
related to psychological functioning associated with
gender (in)congruence and was labeled “psychologi-
cal functioning.” The second factor (six items)
included questions that pertained to distress and
incongruence relating to the genitals and therefore
was named “genitalia.” The third factor (four items)
included questions that asked about the degree to
which participants were satisﬁed with how others
perceived their gender role and therefore these items
were categorized as “social gender role recognition.”
The fourth factor (four items) asked participants
about satisfaction with their physical and emotional
relationships and therefore was named “physical and
emotional intimacy.” The ﬁfth factor (four items)
was labeled “chest” as it included questions that
asked about distress and incongruence with the
chest. The sixth factor (three items) included ques-
tions that were related to distress and incongruence
experienced in relation to non-genital secondary sex
characteristics (e.g., hair, voice) and therefore these
questions were categorized as “other secondary sex
characteristics.” The seventh factor (seven items)
included questions that assessed general life satisfac-
tion (not related to gender incongruence) and there-
fore was labeled “life satisfaction.” From reviewing
these subscales, they appeared to conceptually cluster
into two overarching themes; one that directly
assessed the degree of gender congruence (factors 2,
3, 5, and 6) and another that assessed gender-related
mental well-being and general life satisfaction
(factors 1, 4, and 7). The clusters can be used by cal-
culating the mean scores for the involved items.
Internal consistency
Internal consistency for each of the GCLS subscales
and the global score (comprising all 38 items) were
calculated. All seven subscales were found to have
good (> .7) internal consistency (Nunnally, 1978; see
Table 2) and the internal consistency for the global
score was excellent (a D .95).
Aim 2: Convergent and discriminant validity
In order to test the construct validity of the GCLS (i.e.,
the degree to which the GCLS measures what it claims
to), Spearman’s Rho correlations were conducted
between the GCLS and the WHOQOL, HBDS, TCS,
and IGDS with the transgender participants only (n D
451). Construct validity comprises convergent and
discriminant validity. For the GCLS to show conver-
gent validity (i.e., to determine whether two measures
that theoretically should be related, are related), it
would be expected to have a moderate to high correla-
tion with the WHOQOL, HBDS, and TCS (Evans,
1996). As might be expected, the GCLS physical and
emotional intimacy subscale had a strong signiﬁcant
association with the WHOQOL relationships subscale,
as did the GCLS psychological subscale and the
WHOQOL psychological subscale. Additionally, the
GCLS chest, GCLS genitalia, and GCLS other second-
ary sex characteristics subscales had a moderate to
strong association with the HBDS overall satisfaction
scale. The GCLS social gender role recognition, GCLS
other secondary sex characteristics, GCLS chest, and
GCLS genitalia subscales also all had a moderate to
strong signiﬁcant association with the TCS appearance
congruence subscale. The strongest signiﬁcant associa-
tion was found between the GCLS life satisfaction and
the WHOQOL overall quality of life subscale. These
results conﬁrm the convergent validity of the GCLS
(see Table 3).
Next, correlations were run to determine discrimi-
nant validity, that is, to test whether the GCLS and
IGDS are unrelated (i.e., a weak correlation) as would
theoretically be expected. Table 4 shows that the
GCLS subscales and the IGDS were unrelated as the
two measures are weakly associated with one another
(e.g., below r D .39; Evans, 1996). This suggests that
the GCLS has discriminant validity. It is likely that
some of these correlations will have reached statistical
signiﬁcance due to the large sample size of the current
study (Field, 2013).
Aim 3: Known-groups’ validity
To determine whether the GCLS is capable of distin-
guishing between subgroups (e.g., cisgender people
and transgender people who have had no gender
afﬁrming medical intervention) and to determine
whether groups score in a theoretically expected way
(e.g., people who have undergone gender afﬁrming
medical treatments will be expected to score higher
than people who have not undergone gender afﬁrming
medical treatments on all subscales of the GCLS)
known-groups validity (a further type of construct
validity) was conducted using Mann–Whitney U tests
(Hattie & Cooksey, 1984). Known-groups testing has
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Table 2. Factor loadings, eigenvalues, and percentage of variance each factor explains for the ﬁnal 38 items of the GCLS (second princi-
ple components analysis; n D 451).
Item Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 Factor 6 Factor 7
Factor 1-psychological functioning
(2) I have not gone to school/college/work .79 .02 .01 .01 ¡.04 ¡.05 .09
(6) I have been unable to leave the house .75 ¡.01 ¡.02 .02 .07 ¡.10 ¡.04
(1) I have avoided social situations and/or social interactions .59 ¡.03 .02 .17 .13 ¡.15 ¡.05
(4) I have suffered from anxiety .58 ¡.11 .16 .02 .12 ¡.04 ¡.14
(13) I have thought about hurting myself or taking my own life .56 ¡.21 .04 ¡.01 .05 .01 ¡.26
(11) I have not engaged in leisure activities .51 ¡.05 ¡.07 .19 .29 .00 ¡.15
(8) I have thought about cutting or hurting my chest, genitals, and/or surrounding
areas
.49 ¡.35 .06 ¡.07 .11 .07 ¡.08
(9) I have felt that life is meaningless .47 ¡.17 .03 .12 .07 .01 ¡.37
(12) I have suffered from low mood .46 ¡.12 .16 .08 .18 ¡.01 ¡.27
(7) I have found it difﬁcult to make friends .45 .03 ¡.02 .23 .02 ¡.14 ¡.32
Factor 2-genitalia
(29) I have felt that genital surgery will address the unhappiness I experience in
relation to my gender
.06 ¡.83 ¡.10 .18 ¡.04 ¡.06 .16
(22) I have felt unhappy about my genitalia since they do not match my gender
identity
¡.04 ¡.82 .06 .07 .12 ¡.10 .03
(33) I have felt extremely distressed when looking at my genitals .05 ¡.81 .03 .08 .16 ¡.03 .03
(14) I have felt distressed when touching my genitals as they do not
match my gender identity
.11 ¡.78 .09 .07 .12 ¡.01 .10
(31) I have been unable to have a fulﬁlling life because of the distress relating to my
genitalia
.08 ¡.69 .06 .20 .12 ¡.02 ¡.06
(26) I have felt that my genitals do match with my gender identity# .18 .42 .10 .27 .06 .29 .34
Factor 3-social gender role recognition
(23) I have felt comfortable with how other people perceive my gender based on my
physical appearance#
¡.11 ¡.04 .82 ¡.03 .10 .07 ¡.04
(16) I have felt comfortable with how others have perceived my gender# ¡.02 ¡.03 .79 ¡.01 .02 .06 ¡.04
(20) I have felt satisﬁed with the pronouns that others use when talking about me# .02 .05 .79 .01 ¡.09 ¡.20 .08
(19) I have found it distressing that others do not address me according to my gender
identityy
.40 .04 .39 ¡.09 .18 ¡.33 .21
Factor 4-physical and emotional intimacy
(37) I have felt satisﬁed with my sex life# ¡.19 ¡.25 .14 .76 ¡.02 ¡.08 .03
(36) I have felt satisﬁed with my emotional relationship(s)# ¡.05 ¡.02 .03 .75 .00 ¡.06 ¡.26
(5) I have not been able to be physically intimate with other people .15 ¡.26 ¡.08 .70 .07 ¡.01 .11
(3) I have not been able to have emotional relationships with other people .32 ¡.01 ¡.07 .63 .08 ¡.07 ¡.06
Factor 5-chest
(34) I have felt satisﬁed with my chest# ¡.16 .08 .02 .05 .94 ¡.08 ¡.01
(18) I have felt like my chest does not match my gender identity ¡.12 .01 .07 ¡.03 .92 ¡.11 .03
(32) I have felt extremely distressed when looking at my chest .10 ¡.19 .01 ¡.06 .81 ¡.01 ¡.01
(15) I have felt so distressed about my chest that I have not been able to have a
fulﬁlling life
.22 ¡.14 ¡.05 ¡.07 .76 .08 ¡.01
Factor 6-other secondary sex characteristics
(17) I have felt that my body hair conﬂicts with my gender identity, either because I
have it and do not like it or because I would like to have it
.01 ¡.03 .02 .09 .07 ¡.80 ¡.03
(25) I have felt that my facial hair conﬂicts with my gender identity, either because I
have it and do not like it or because I would like to have it
.04 ¡.12 ¡.01 .01 .12 ¡.78 ¡.02
(24) I have felt that my voice has affected the way other people have perceived my
gender identity which has been distressing for me
.28 ¡.01 .16 .06 .14 ¡.53 .19
Factor 7-life satisfaction
(39) I have not felt satisﬁed with my friends .11 .15 ¡.04 .07 .10 ¡.03 ¡.65
(40) I have felt satisﬁed with the support I have received from other signiﬁcant people# ¡.04 .20 .15 .31 .01 ¡.22 ¡.48
(42) I have felt satisﬁed with life in general# .07 ¡.09 .30 .16 .09 .04 ¡.48
(38) I have felt satisﬁed in my leisure activities and hobbies# .14 ¡.03 .14 .22 .21 .08 ¡.45
(35) I have felt satisﬁed at school/college/work# .21 ¡.05 .24 .13 ¡.05 ¡.01 ¡.39
(41) I have not felt satisﬁed with my health .30 .01 .14 ¡.12 .03 .05 ¡.39
(10) I have not enjoyed life .38 ¡.18 .15 .19 .08 .02 ¡.39
Items removed for conceptual reasons (from ﬁrst principle components analysis)
(21) I have felt depressed when looking in the mirror as the body I have does not
match my gender identity)
.10 ¡.37 .06 ¡.01 .03 .54 ¡.11
(27) I have felt that the way my body looks naked does not represent my gender
identity
¡.06 ¡.46 .07 .05 .07 .50 ¡.03
(28) I have felt distressed about my gender as my body does not match my gender
identity
.11 ¡.49 .10 ¡.03 .12 .40 ¡.01
(30) I have felt that I do not need sex hormones to make me feel happy about my
gender
.10 ¡.26 ¡.43 .20 .26 .04 .05
Eigenvalue 14.83 3.35 2.30 1.84 1.24 1.21 1.07
Variance explained (%) 39.03 8.82 6.04 4.85 3.25 3.20 2.82
Cronbach’s alpha .93 .79 .77 .85 .92 .81 .83
Note. GCLS: Gender Congruence and Life Satisfaction Scale; salient factor loadings are in bold; # indicates reverse scored items (n D 11); y item 19 was retained
within factor 3 (rather than factor 1) for conceptual reasons.
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previously been used to assess the construct validity of
self-report measures (e.g., Alvarenga, Scagliusi, & Phil-
ippi, 2010). In the current study, some of these analy-
ses were conducted between known-groups within the
transgender sample, and some between transgender
and cisgender participants. These analyses are not
exhaustive but provide subscale and cluster norms for
the different groups explored.
Initially, responses on the GCLS for transgender
participants who had not undergone any gender
afﬁrming medical treatment (n D 189) and cisgender
people (n D 338) were compared. It was found that
the cisgender participants scored signiﬁcantly higher
(indicating a more positive outcome) on all GCLS sub-
scales and the global scale than transgender people
who had not undergone any gender afﬁrming medical
interventions (see Table 5). Responses between the
two groups were also compared on the GCLS clusters
previously identiﬁed. It was found that cisgender peo-
ple scored signiﬁcantly higher (indicative of a more
positive outcome) than transgender people who were
yet to undergo gender afﬁrming medical interventions
on the gender congruence cluster and the gender-
related mental well-being and life satisfaction cluster
(see Table 5). All effect sizes for the comparative anal-
ysis were large (Field, 2009).
Next, a Mann–Whitney U test was conducted to
compare responses on the GCLS between transgender
males who had not undergone any gender afﬁrming
medical intervention (n D 46) and transgender males
who had taken cross-sex hormone treatment and
undergone chest reconstructive (but not genital) sur-
gery (n D 17). Within the UK (which is where these
data were collected), chest reconstructive surgery is
funded by the NHS. However, breast augmentation
surgery is not funded, hence these analyses were only
conducted in relation to transgender males. The
analyses demonstrated that transgender males who
had taken cross-sex hormones and undergone chest
reconstructive surgery scored signiﬁcantly higher
(more positive outcome) on the psychological func-
tioning, social gender role recognition, chest, other sec-
ondary sex characteristics, and life satisfaction
subscales of the GCLS as well as the global scale, than
transgender males who had not undergone any gender
afﬁrming medial intervention (see Table 6). No signiﬁ-
cant differences were found between the two groups on
the genitalia and physical and emotional intimacy sub-
scales of the GCLS. The two groups were also com-
pared on the GCLS clusters and it was found that
Table 3. Spearman’s Rho correlation matrix between GCLS, HBDS, TCS, and WHOQOL assessing convergent validity (n D 451; transgen-
der participants only).
1 2 3 4 5 6 7 8 9 10 11 12
1 GCLS: psychological functioning —
2 GCLS: genitalia .52*** —
3 GCLS: social gender role recognition .51*** .26*** —
4 GCLS: physical and emotional intimacy .60*** .50*** .30*** —
5 GCLS: chest .61*** .55*** .49*** .41*** —
6 GCLS: other secondary sex characteristics .50*** .48*** .48*** .42*** .54*** —
7 GCLS: life satisfaction .76*** .34*** .52*** .56*** .47*** .40*** —
8 GCLS: global .90*** .70*** .63*** .70*** .78*** .69*** .80*** —
9 TCS: appearance congruence .46*** .43*** .63*** .36*** .56*** .50*** .51*** .62*** —
10 HBDS: overall satisfaction .58*** .42*** .46*** .44*** .56*** .54*** .56*** .67*** .62*** —
11 WHOQOL: overall .62*** .27*** .42*** .46*** .41*** .35*** .74*** .62*** .45*** .51*** —
12 WHOQOL: psychological .66*** .41*** .44*** .51*** .51*** .41*** .74*** .71*** .54*** .63*** .73*** —
13 WHOQOL: relationships .44*** .34*** .23*** .73*** .27*** .34*** .58*** .54*** .32*** .39*** .52*** .53***
Note. GCLS: Gender Congruence and Life Satisfaction Scale; TCS: Transgender Congruence Scale; WHOQOL-BREF: WHO Quality of Life-BREF; HBDS: Hamburg Body
Drawing Scale.
p < .05.
p < .01.
p < .001 (corrected for multiple comparisons).
Table 4. One-tailed Spearman’s Rho correlations between the
GCLS and the IGDS to assess discriminant validity (n D 451; trans-
gender participants only).
GCLS subscales IGDS
Psychological functioning ¡.27***
Genitalia ¡.10**
Social gender role recognition ¡.19***
Physical and emotional intimacy ¡.16***
Chest ¡.14***
Other secondary sex characteristics ¡.08
Life satisfaction ¡.28***
Global ¡.24***
Note. GCLS: Gender Congruence and Life Satisfaction Scale; IGDS: Internet
Gaming Disorder Scale.
p < .05.
p < .01.
p < .001.
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transgender males who had taken cross-sex hormones
and undergone chest reconstructive surgery scored sig-
niﬁcantly higher (more positive outcome) on the gen-
der congruence cluster and the gender-related mental
well-being and life satisfaction cluster than transgender
males who had not undergone any gender afﬁrming
medical interventions (see Table 6). Effect sizes for the
comparative analysis were large (social gender role rec-
ognition; chest; other secondary sex characteristics;
global scale; and cluster one), medium (psychological
functioning; cluster two), and small (genitalia; physical
and emotional intimacy; life satisfaction; Field, 2009).
Finally, a Mann–Whitney U test was conducted
between responses on the GCLS for transgender par-
ticipants who were yet to undergo any gender afﬁrm-
ing medical intervention (n D 189) and people who
had taken cross-sex hormone treatment and under-
gone genital surgery (C / – chest reconstructive sur-
gery; n D 92). People who had taken cross-sex
hormone treatment and undergone genital surgery
(C / – chest reconstructive surgery) scored signiﬁ-
cantly higher (more positive outcome) on all GCLS
subscales and the global scale compared to people
who had not undergone any gender afﬁrming medical
interventions (see Table 7). The groups were also
compared on the two clusters and it was found that
transgender people who had taken cross-sex hormone
treatment and undergone genital surgery (C / – chest
reconstructive surgery) scored signiﬁcantly higher
(more positive outcome) on the gender congruence
cluster and the gender-related mental well-being and
life satisfaction cluster than people who had not
undergone any gender afﬁrming medical intervention
(see Table 7). Effect sizes for the comparative analysis
were large (social gender role recognition; chest; clus-
ter one), medium (psychological functioning; other
secondary sex characteristics; life satisfaction; global
scale; cluster two), and small (genitalia; physical and
emotional intimacy; Field, 2009).
Summary of analysis
Factor analysis on items of the GCLS supported a 7-
factor solution with 38 items retained in total. The
Table 5. Mann–Whitney U test scores for transgender people who have undergone no GAMI (n D 189) versus cisgender people (n D
338) on the GCLS.
No GAMI group Cisgender group
Mann–Whitney U
M (SD) M (SD) U z Effect size p
Psychological functioning 3.36 (1.01) 4.84 (.41) 3830.50 ¡17.96 .78 .001
Genitalia 3.22 (1.04) 4.54 (.33) 7063.50 ¡15.56 .68 .001
Social gender role recognition 2.73 (.83) 4.03 (1.07) 11650.00 ¡12.21 .53 .001
Physical and emotional intimacy 2.98 (1.07) 4.26 (.61) 10492.00 ¡12.85 .56 .001
Chest 2.57 (1.17) 4.60 (.50) 3835.00 ¡16.99 .74 .001
Other secondary sex characteristics 2.55 (1.25) 4.79 (.47) 3811.00 ¡18.03 .79 .001
Life satisfaction 3.06 (.77) 3.90 (.61) 12609.50 ¡11.55 .50 .001
Global GCLS 3.03 (.78) 4.45 (.31) 2398.50 ¡17.62 .77 .001
Cluster 1: gender congruence 2.83 (.84) 4.48 (.37) 2228.00 ¡17.74 .77 .001
Cluster 2: gender-related mental well-being and life satisfaction 3.18 (.84) 4.41 (.40) 5850.50 ¡15.57 .68 .001
Note. GCLS: Gender Congruence and Life Satisfaction Scale; GAMI: Gender Afﬁrming Medical Intervention.
Table 6. Mann–Whitney U test scores for transgender males who have undergone no GAMI (n D 46) versus transgender males who are
taking CHT and have undergone chest reconstructive surgery (n D 17) on the GCLS.
Transgender males:
no GAMI
Transgender males: CHT
and chest surgery
Mann–Whitney U
M (SD) M (SD) U z Effect size p
Psychological functioning 2.82 (.79) 3.64 (.70) 180.00 ¡3.27 .41 .001
Genitalia 2.49 (.93) 2.79 (.95) 306.50 ¡1.31 .17 .098
Social gender role recognition 2.63 (.76) 3.76 (1.01) 110.00 ¡4.37 .55 .001
Physical and emotional intimacy 2.64 (1.04) 3.08 (1.02) 301.00 ¡1.40 .18 .083
Chest 1.54 (.66) 4.24 (1.14) 35.50 ¡5.58 .70 .001
Other secondary sex characteristics 1.91 (.91) 3.63 (1.29) 83.00 ¡4.80 .60 .001
Life satisfaction 2.90 (.64) 3.39 (.71) 245.00 ¡2.27 .29 .001
Global GCLS 2.54 (.57) 3.48 (.60) 95.50 ¡4.58 .58 .001
Cluster 1: gender congruence 2.20 (.55) 3.51 (.76) 66.00 ¡5.04 .63 .001
Cluster 2: gender-related mental well-being and life satisfaction 2.81 (.68) 3.45 (.66) 210.50 ¡2.80 .35 .002
Note. GCLS: Gender Congruence and Life Satisfaction Scale; CHT: Cross-sex Hormone Treatment; GAMI: Gender Afﬁrming Medical Intervention.
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seven subscales are: psychological functioning;
genitalia; social gender role recognition; physical and
emotional intimacy; chest; other secondary sex charac-
teristics; and life satisfaction. The subscales can be cate-
gorized into two clusters; (1) gender congruence
(genitalia, chest, other secondary sex characteristics,
and social gender role recognition), and (2) gender-
related mental well-being and general life satisfaction
(physical and emotional intimacy, psychological func-
tioning, and life satisfaction). A higher score indicates a
greater gender congruence, greater gender-related
well-being, and greater life satisfaction. The GCLS sub-
scales and the global scale have undergone vigorous
testing and have demonstrated good reliability and
validity. Subscale, global scale, and cluster norms for
transgender people at different stages of medical transi-
tion, as well as cisgender people have been generated.
The known-groups’ analysis also demonstrated that
the measure is capable of discriminating between
groups of interest (e.g., people who have and have not
undergone gender afﬁrming medical interventions)
and highlights how gender incongruence, gender-
related mental well-being, and general life satisfaction
improve over the course of the medical transition. It
can therefore be concluded that the GCLS is a suitable
tool to use with the transgender population to measure
gender congruence and life satisfaction, and—in partic-
ular—improvements in these that are likely to occur
during the treatment process.
Discussion
The main aim of this study was to develop and evaluate
a new transgender health outcome measure: the Gen-
der Congruence and Life Satisfaction Scale (GCLS)
which is capable of measuring changes in gender
congruence and life satisfaction over the course of gen-
der afﬁrming medical interventions. The GCLS is the
ﬁrst transgender health outcome measure that can be
used independently of gender assigned at birth and
gender identity. This study conﬁrmed that the GCLS is
a valid and reliable measure to use with the transgender
population and is capable of producing high quality
outcome data for clinical and research purposes.
Clinical utility of the GCLS
Having a brief, self-report questionnaire that is capa-
ble of assessing transgender health outcomes is impor-
tant in order to measure the quality of care that is
offered at transgender health services (Dawson et al.,
2010), to enable transgender patients to be followed-
up over time (both before and after gender afﬁrming
medical interventions), and to determine what trans-
gender healthcare needs people require. The latter
may help with ﬁnancial planning and future work-
force and service development in the ﬁeld of transgen-
der healthcare.
The GCLS was developed in collaboration with
the transgender population and healthcare profes-
sionals working in the ﬁeld of transgender health.
This has ensured that the GCLS is meaningful and
relevant for use as an outcome measure for people
attending transgender health services (T’Sjoen,
Motmans, Arcelus, & Bouman, 2017). Factor analy-
sis suggested the retention of 38 items, which com-
prised seven subscales (psychological functioning,
genitalia, social gender role recognition, physical
and emotional intimacy, chest, other secondary sex
characteristics, and life satisfaction) that were clus-
tered into two themes: (1) gender congruence and
(2) gender-related mental well-being and general
Table 7. Mann–Whitney U test scores for transgender people who have not undergone any GAMI (n D 189) versus transgender people
who have taken CHT and undergone genital surgery (C/¡ chest reconstructive surgery; n D 92) on the GCLS.
No GAMI group
CHT and genital surgery
(C/¡chest surgery)
Mann–Whitney U
M (SD) M (SD) U z Effect size p
Psychological functioning 3.36 (1.01) 4.15 (.72) 4687.50 ¡6.27 .37 .001
Genitalia 3.22 (1.04) 3.81 (.92) 5858.00 ¡4.33 .26 .001
Social gender role recognition 2.73 (.83) 3.93 (.73) 2523.50 ¡9.68 .58 .001
Physical and emotional intimacy 2.98 (1.07) 3.36 (1.14) 6923.50 ¡2.65 .16 .001
Chest 2.57 (1.17) 4.27 (.89) 2174.50 ¡10.15 .61 .001
Other secondary sex characteristics 2.55 (1.25) 3.65 (1.10) 4484.00 ¡6.61 .39 .001
Life satisfaction 3.06 (.77) 3.72 (.72) 4537.00 ¡6.51 .39 .001
Global GCLS 3.03 (.78) 3.88 (.60) 3461.50 ¡8.19 .49 .001
Cluster 1: gender congruence 2.83 (.84) 3.92 (.61) 2761.00 ¡9.28 .55 .001
Cluster 2: gender-related mental well-being and life satisfaction 3.18 (.84) 3.86 (.70) 4755.00 ¡6.16 .37 .001
Note. GCLS: Gender Congruence and Life Satisfaction Scale; CHT: Cross-sex Hormone Treatment; GAMI: Gender Afﬁrming Medical Intervention.
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life satisfaction. The two clusters have clinical rele-
vance and applicability as some transgender people
may or may not experience mental health problems
in association with the distress and unhappiness
they experience with their gender (e.g., Dhejne
et al., 2016). The existence of two separate clusters
therefore allows these factors to be considered sep-
arately. In addition, the outcome of transgender
health services can be divided into outcomes
related to the symptomatology that the individual
presents to the service with (i.e., gender incongru-
ence and gender dysphoria) and outcomes that
relate to psychological well-being (life satisfaction
and mental health). Being able to review the scores
on these two clusters may allow clinicians and
healthcare professionals to deliver a patient-cen-
tered service. The delivery of patient-centered inter-
ventions is crucial to improve patient outcomes
(e.g., Lauver et al., 2002). The mean scores given
for each subscale, the global score, and cluster of
the GCLS for transgender people at different stages
of medical transition within the current study can
be used as norms. Subscale and cluster norms have
also been provided for cisgender people; a sample
that may provide a useful reference point for both
future clinical and research purposes.
Research utility of the GCLS
It is expected that the GCLS may not only be a useful
clinical tool, but may also aid research in the ﬁeld of
transgender health. As part of the validation process,
the GCLS has already demonstrated that it can distin-
guish between subgroups of transgender individuals
who are at different stages of medical transition, which
makes it a suitable research tool. The current study
found that transgender people who had not under-
gone any gender afﬁrming medical interventions
reported worse outcomes on all GCLS subscales, the
global scale, and two clusters than both cisgender peo-
ple and transgender people who had taken cross-sex
hormone treatment and undergone genital surgery (C
/ – chest reconstructive surgery). These ﬁndings sup-
port previous research that has shown patients to
report less distress with their gender, lower levels of
body dissatisfaction, better mental well-being, and
greater life satisfaction after they had undergone gen-
der afﬁrming surgery (e.g., Dhejne et al., 2016; Jones
et al., 2016; Marinkovic and Newﬁeld, 2017; Marshall
et al., 2016; Murad et al., 2010; van de Grift et al.,
2018; Witcomb et al., 2018).
This study also found that transgender males who
had not undergone any gender afﬁrming medical
intervention reported worse outcomes on the chest,
other secondary sex characteristics, social gender role
recognition, psychological functioning, and life satis-
faction subscales of the GCLS, as well as the global
scale and the two clusters, than transgender males
who had taken cross-sex hormone treatment and
undergone chest reconstructive surgery. There was no
signiﬁcant difference between the two groups on the
genitalia and physical and emotional intimacy sub-
scales of the GCLS. This ﬁnding supports previous
research, which has found dissatisfaction and distress
with the genitalia to be increasingly prevalent post-
chest reconstructive surgery in treatment-seeking
transgender men (van de Grift et al., 2016). Research
with cisgender populations has found body dissatisfac-
tion (Woertman & van den Brink, 2012), as well as
speciﬁc genital dissatisfaction (Schick, Calabrese,
Rima, & Zucker, 2010), to affect sexual satisfaction
and therefore the high levels of dissatisfaction and dis-
tress experienced in relation to the genitalia in trans-
gender men in the current study (pre-genital surgery)
is likely to impact on their physical relationships.
The analysis we conducted with known-groups
demonstrates the sensitivity of the GCLS and its ability
to distinguish between outcomes at different stages of
medical transition (e.g., chest distress dissipates post-
chest reconstructive surgery). Having a validated tool
that is capable of having this level of sensitivity may be
extremely useful in advancing research in transgender
health. For instance, when the length of time a person
has been on cross-sex hormone treatment is known,
longitudinal research may be able to identify a time
frame in which long-term outcomes, such as psycho-
logical functioning and life satisfaction, improve.
Establishing this in different subgroups (e.g., people
who identify as non-binary) is also important. The
GCLS has been developed independent of gender
assigned at birth and gender identity and therefore
may also be an appropriate measure to use with those
who identify as non-binary. Research with this popula-
tion is in its infancy, but suggests poorer mental health
than binary transgender people (Rimes, Goodship,
Ussher, Baker, & West, 2017; Scottish Trans Alliance,
2015; Thorne, Witcomb, Nieder, Nixon, & Arcelus,
2018; Warren, Smalley, & Barefoot, 2016). Some of the
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subscales from the GCLS may also be used to advance
knowledge concerning factors that predict good out-
comes in transgender people, for example, factors that
predict life satisfaction. Establishing factors that predict
a good outcome among individuals who identify as
non-binary is also essential as the factors are likely to
differ to what is seen among transgender people who
identify within the binary gender system.
The GCLS is the ﬁrst transgender health outcome
measure to be developed and validated with the
transgender population and is capable of assessing
important treatment outcomes for treatment seeking
binary and non-binary identifying people. However,
there are some limitations to be considered. First, the
GCLS was only validated in an English speaking
adult population. Future research should focus on
validating the GCLS in other languages and other age
groups (e.g., children and adolescents). Second,
although gender incongruence, related mental well-
being, and life satisfaction were all found to improve
over the course of gender afﬁrming medical interven-
tions in the current study, it must be considered that
these conclusions were based on cross-sectional data
and test re-test reliability was not established. In
addition to this, data were not collected in relation to
whether or not participants were accessing transgen-
der health services (i.e., were treatment seeking) or
the length of time on cross-sex hormone treatment.
To further explore the short- and long-term out-
comes of gender afﬁrming medical interventions,
longitudinal research that uses the GCLS in treat-
ment seeking transgender people needs to be con-
ducted. The gender of the cisgender participants
within this study was also skewed (i.e., the majority
were cisgender women). Future research should look
to employ the GCLS with a larger sample of cisgen-
der males to compare scores with transgender males.
Contrary to expectations, some subscales of the
GCLS signiﬁcantly correlated with the IGDS. This is
likely to be due to the large sample size in the current
study (Field, 2013). However, this ﬁnding may war-
rant further research into gaming behavior of trans-
gender people.
In conclusion, the ﬁndings from this study suggest
that the GCLS is a suitable and robust measure to
assess treatment outcomes in relation to gender con-
gruence, related mental well-being, and life satisfac-
tion within the transgender population in both a
clinical and research capacity. Having a measure that
is capable of assessing these outcomes may allow for
the quality of gender afﬁrming interventions to be
improved within transgender health services, and thus
may improve the quality of life of transgender people
and their families of choice.
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APPENDIX
Citation and tool use: The GCLS is freely available for
use. To reference the measure, please cite this publica-
tion. Please contact the authors if you have any ques-
tions about the scale:
Beth Jones: B.Jones@lboro.ac.uk
Prof Jon Arcelus: Jon.Arcelus@nottingham.ac.uk
If you would like to use the tool in a different lan-
guage (i.e., translate it) then please contact the authors
as they may already have it available in your language.
This will avoid several versions of the tool being cre-
ated in the same language. We hope you ﬁnd this tool
useful.
Scoring instructions: Items are scored on a 5-point
scale (always D 1; never D 5). Items with an asterisk
(indicated below) need to be reverse scored (always D
5, never D 1). A higher score therefore indicates a
more positive outcome (higher gender congruence,
better gender-related mental well-being, and better
general life satisfaction).
To score item 26, if the participant indicates (by
ticking the box) that they have had genital surgery,
score their response as missing data. If they have
not ticked the box, score their response as for the
other GCLS items (always D 1; never D 5).
To obtain subscale scores and the global score, cal-
culate the mean score. The global score comprises all
38 items. The items that comprise each subscale are
listed below:
1. Genitalia: 14, 21, 25

, 26, 27, and 29 (6 items)
2. Chest: 15, 18, 28, and 30

(4 items)
3. Other secondary sex characteristics: 17, 23, and
24 (3 items)
4. Social gender role recognition: 16

, 19, 20

, and
22

(4 items)
5. Physical and emotional intimacy: 3, 5, 32

, and
33

(4 items)
6. Psychological functioning: 1, 2, 4, 6, 7, 8, 9, 11,
12, and 13 (10 items)
7. Life satisfaction: 10, 31

, 34

, 35, 36

, 37, and 38

(7 items)
The subscales can also be grouped into two clusters.
Cluster 1, gender congruence, comprises subscales 1–
4, and cluster 2, gender-related mental well-being
and life satisfaction, comprises subscale 5–7. To
obtain the cluster scores, calculate the mean of all the
items in that cluster:
Cluster 1 (gender congruence): 14, 15, 16

, 17, 18,
19, 20

, 21, 22

, 23, 24, 25

, 26, 27, 28, 29, 30

Cluster 2 (gender-related mental well-being
and general life satisfaction): 1, 2, 3, 4, 5, 6,
7, 8, 9, 10, 11, 12, 13, 31

, 32

, 33

, 34

, 35, 36

,
37, 38

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Gender Congruence and Life Satisfaction Scale
(GCLS)
Below is a range of statements about how you might feel in
relation to your gender, mental well-being, and life satisfac-
tion. Please respond to each statement, thinking about how
frequently you have felt like this in the past 6 months.
Please rate each statement as: NEVER (N),
RARELY (R), SOMETIMES (S), OFTEN (O), or
ALWAYS (A).
Please note that when talking about ‘‘gender iden-
tity” we mean one’s internal sense of one’s self as a
man, a woman, or some other gender.
In the past 6 months, due to the distress about my gender (i.e., the distress caused as
the gender I was assigned at birth does not match with my gender identity):
1. I have avoided social situations and/or social interactions N R S O A
2. I have not gone to school/college/work N R S O A
3. I have not been able to have emotional relationships with other people N R S O A
4. I have suffered from anxiety N R S O A
5. I have not been able to be physically intimate with other people N R S O A
6. I have been unable to leave the house N R S O A
7. I have found it difﬁcult to make friends N R S O A
8. I have thought about cutting or hurting my chest, genitals, and/or surrounding areas N R S O A
9. I have felt that life is meaningless N R S O A
10. I have not enjoyed life N R S O A
11. I have not engaged in leisure activities N R S O A
12. I have suffered from low mood N R S O A
13. I have thought about hurting myself or taking my own life N R S O A
Please rate each statement as: NEVER (N), RARELY (R), SOMETIMES (S), OFTEN (O), or ALWAYS (A).
In the past 6 months:
14. I have felt distressed when touching my genitals as they do not match my gender
identity
N R S O A
15. I have felt so distressed about my chest that I have not been able to have a fulﬁlling
life
N R S O A
16. I have felt comfortable with how others have perceived my gender N R S O A
17. I have felt that my body hair conﬂicts with my gender identity, either because I have it
and do not like it or because I would like to have it
N R S O A
18. I have felt like my chest does not match my gender identity N R S O A
19. I have found it distressing that others do not address me according to my gender
identity
N R S O A
20. I have felt satisﬁed with the pronouns that others use when talking about me N R S O A
21. I have felt unhappy about my genitalia since they do not match my gender identity N R S O A
22. I have felt comfortable with how other people perceive my gender based on my
physical appearance
N R S O A
23. I have felt that my voice has affected the way other people have perceived my gender
identity which has been distressing for me
N R S O A
24. I have felt that my facial hair conﬂicts with my gender identity, either because I have it
and do not like it or because I would like to have it
N R S O A
25. I have felt that my genitals do match with my gender identity N R S O A
26. I have felt that genital surgery will address the unhappiness I experience in relation to
my gender
N R S O A
&. Tick here if you have already had genital surgery (unless you feel you need more)
27. I have been unable to have a fulﬁlling life because of the distress relating to my
genitalia
N R S O A
28. I have felt extremely distressed when looking at my chest N R S O A
29. I have felt extremely distressed when looking at my genitals N R S O A
30. I have felt satisﬁed with my chest N R S O A
Please rate each statement as: NEVER (N), RARELY (R), SOMETIMES (S), OFTEN (O), or ALWAYS (A).
Next, we would like to know how satisﬁed you have been with your life for the last 6 months:
31. I have felt satisﬁed at school/college/work N R S O A
32. I have felt satisﬁed with my emotional relationship(s) N R S O A
33. I have felt satisﬁed with my sex life N R S O A
34. I have felt satisﬁed in my leisure activities and hobbies N R S O A
35. I have not felt satisﬁed with my friends N R S O A
36. I have felt satisﬁed with the support I have received from other signiﬁcant people N R S O A
37. I have not felt satisﬁed with my health N R S O A
38. I have felt satisﬁed with life in general N R S O A
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